Tech Company Financing Transactions
Stemcentrx Funding Round
Stemcentrx closed a $250 million funding round on 8/31/2015. Investors included Founders Fund and Fidelity Management & Research Company.
Transaction Overview
Company Name
Announced On
8/31/2015
Transaction Type
Venture Equity
Amount
$250,000,000
Round
Undisclosed
Investors
Founders Fund (Lead Investor) (Peter Thiel)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
450 E Jamie Ct.
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Our mission is to develop therapies that cure and significantly improve survival for cancer patients. We are pioneering new approaches to eliminate cancer stem cells, which initiate and perpetuate tumors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Slingerland
Chief Operating Officer
James Strawbridge
Chief Scientific Officer
Scott Dylla
VP - R & D
Robert Garnick
Browse more venture capital transactions:
Prev: 8/31/2015: Kidizen venture capital transaction
Next: 8/31/2015: Snapcard venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs